Zhenqiang Sun

6.3k total citations · 7 hit papers
59 papers, 4.3k citations indexed

About

Zhenqiang Sun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhenqiang Sun has authored 59 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Zhenqiang Sun's work include Cancer-related molecular mechanisms research (15 papers), Cancer Immunotherapy and Biomarkers (15 papers) and MicroRNA in disease regulation (12 papers). Zhenqiang Sun is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), Cancer Immunotherapy and Biomarkers (15 papers) and MicroRNA in disease regulation (12 papers). Zhenqiang Sun collaborates with scholars based in China and Saudi Arabia. Zhenqiang Sun's co-authors include Weitang Yuan, Quanbo Zhou, Guixian Wang, Jinbo Liu, Chen Chen, Shengyun Hu, Junmin Song, Yaxin Guo, Chengzeng Wang and Xiang Ji and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Zhenqiang Sun

58 papers receiving 4.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of exosomal miRNA on cancer biology and clinical applications

2018 625 citations Zhenqiang Sun, Shuaixi Yang et al. Molecular Cancer profile →
The interplay between m6A RNA methylation and noncoding RNA in cancer

2019 469 citations Shuai Ma, Chen Chen et al. Journal of Hematology & Oncology profile →
Engineered exosomes from different sources for cancer-targeted therapy

2023 292 citations Shengyun Hu, Yang Liu et al. profile →
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

2023 216 citations Shengyun Hu, Weitang Yuan et al. Molecular Cancer profile →
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers

2023 152 citations Zhenqiang Sun, Chengzeng Wang et al. Molecular Cancer profile →
Breakthrough of solid tumor treatment: CAR-NK immunotherapy

2024 74 citations Wenkang Wang, Yang Liu et al. profile →
Roles of exosomes in immunotherapy for solid cancers

2024 69 citations Haifeng Sun, Zhenqiang Sun et al. Cell Death and Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenqiang Sun China	32	3.1k	2.2k	937	762	444	59	4.3k
Nehad M. Alajez Qatar	37	3.0k 1.0×	2.2k 1.0×	922 1.0×	575 0.8×	336 0.8×	120	4.4k
Weitang Yuan China	31	3.8k 1.2×	2.9k 1.4×	946 1.0×	631 0.8×	410 0.9×	84	5.1k
Xuan Zhou China	36	3.1k 1.0×	2.4k 1.1×	1.2k 1.3×	504 0.7×	289 0.7×	160	4.7k
Minghui Wang China	32	2.2k 0.7×	1.4k 0.7×	1.0k 1.1×	521 0.7×	599 1.3×	137	3.9k
Renbing Jia China	35	2.5k 0.8×	1.4k 0.7×	950 1.0×	558 0.7×	284 0.6×	174	4.4k
Aija Linē Latvia	26	1.9k 0.6×	1.0k 0.5×	768 0.8×	635 0.8×	321 0.7×	63	2.9k
Quanbo Zhou China	36	4.3k 1.4×	3.6k 1.6×	1.2k 1.3×	610 0.8×	416 0.9×	93	5.7k
Mariam Grigorian Denmark	37	3.3k 1.1×	1.4k 0.7×	612 0.7×	1.2k 1.6×	451 1.0×	68	4.6k
Chao Ge China	35	2.4k 0.8×	1.7k 0.8×	1.2k 1.3×	337 0.4×	373 0.8×	87	3.9k

Countries citing papers authored by Zhenqiang Sun

Since Specialization

Citations

This map shows the geographic impact of Zhenqiang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenqiang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenqiang Sun more than expected).

Fields of papers citing papers by Zhenqiang Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenqiang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenqiang Sun. The network helps show where Zhenqiang Sun may publish in the future.

Co-authorship network of co-authors of Zhenqiang Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenqiang Sun. A scholar is included among the top collaborators of Zhenqiang Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenqiang Sun. Zhenqiang Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Yan, et al.. (2025). Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application. Cell Death and Disease. 16(1). 277–277. 10 indexed citations

Yang, Yuanyuan, et al.. (2025). Spatial omics technology potentially promotes the progress of tumor immunotherapy. British Journal of Cancer. 133(4). 421–434. 2 indexed citations

Sun, Haifeng, et al.. (2024). Roles of exosomes in immunotherapy for solid cancers. Cell Death and Disease. 15(2). 106–106. 69 indexed citations breakdown →

Han, Mingyu, Haifeng Sun, Quanbo Zhou, et al.. (2023). Effects of RNA methylation on Tumor angiogenesis and cancer progression. Molecular Cancer. 22(1). 25 indexed citations

Ming, Yue, Shengyun Hu, Haifeng Sun, et al.. (2023). Extracellular vesicles remodel tumor environment for cancer immunotherapy. Molecular Cancer. 22(1). 203–203. 65 indexed citations

Liu, Zaoqu, Siyuan Weng, Qin Dang, et al.. (2022). Gene interaction perturbation network deciphers a high-resolution taxonomy in colorectal cancer. eLife. 11. 13 indexed citations

Liu, Yang, Wenkang Wang, Weitang Yuan, et al.. (2022). Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect. British Journal of Cancer. 128(5). 715–725. 52 indexed citations

Liu, Zaoqu, Yaxin Guo, Xiuxiu Yang, et al.. (2022). Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies. Frontiers in Cell and Developmental Biology. 9. 784199–784199. 17 indexed citations

Chen, Zhuang, Qin Dang, Chen Chen, et al.. (2022). Roles of exosomal circRNAs in tumour immunity and cancer progression. Cell Death and Disease. 13(6). 539–539. 30 indexed citations

10.

Shi, Ke, Shuaixi Yang, Chen Chen, et al.. (2022). RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis. International Journal of Biological Sciences. 18(7). 3048–3065. 19 indexed citations

11.

Liu, Zaoqu, Long Liu, Dechao Jiao, et al.. (2021). Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma. Frontiers in Genetics. 12. 669694–669694. 38 indexed citations

12.

Cui, Wenming, Qin Dang, Chen Chen, Weitang Yuan, & Zhenqiang Sun. (2021). Roles of circRNAs on tumor autophagy. Molecular Therapy — Nucleic Acids. 23. 918–929. 17 indexed citations

13.

Liu, Zaoqu, Yuyuan Zhang, Qin Dang, et al.. (2021). Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1. Frontiers in Oncology. 11. 632430–632430. 36 indexed citations

14.

Dang, Qin, Bo Shao, Quanbo Zhou, et al.. (2021). RNA N6-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications. Frontiers in Oncology. 11. 681781–681781. 13 indexed citations

15.

Liu, Zaoqu, Yuyuan Zhang, Chengcheng Shi, et al.. (2021). A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma. Journal of Translational Medicine. 19(1). 5–5. 76 indexed citations

16.

Liu, Jinbo, Quanbo Zhou, Junmin Song, et al.. (2020). Exosomal Noncoding RNAs and Tumor Drug Resistance. Cancer Research. 80(20). 4307–4313. 33 indexed citations

17.

Ma, Shuai, Chen Chen, Xiang Ji, et al.. (2019). The interplay between m6A RNA methylation and noncoding RNA in cancer. Journal of Hematology & Oncology. 12(1). 121–121. 469 indexed citations breakdown →

18.

Ren, Weiguo, Shourong Shen, Zhenqiang Sun, et al.. (2016). Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A DCAF1 to promote colon cancer development. Cancer Letters. 375(2). 209–220. 36 indexed citations

19.

Sun, Zhenqiang, Weiguo Ren, Chunlin Ou, et al.. (2015). Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis. PLoS ONE. 10(8). e0135119–e0135119. 37 indexed citations

20.

Ou, Chunlin, Zhenqiang Sun, Han Zhang, et al.. (2015). SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway. Oncology Reports. 33(6). 2779–2788. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact